Glucagonoma - 50 Studies Found
Active, not recruiting |
: Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors :
|
Active, not recruiting |
: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors :
|
Completed |
: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors :
|
Terminated |
: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors :
|
Completed |
: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors :
|
Terminated |
: Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer :
|
Completed |
: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu :
|
Completed |
: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma :
|
Completed |
: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer :
|
Recruiting |
: Laser Tissue Welding - Distal Pancreatectomy Sealing Study :
|